A post-hoc analysis of the study showed DTG/3TC was non-inferior to 3-drug therapy regardless of the participant’s baseline viral load. These data were presented at HIV Glasgow 2024, being held ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The firm decreased its portfolio allocation in DTG by 6.04% over the last quarter ... and small hedge funds. Our data covers the world, and includes fundamentals, analyst reports, ownership ...

Data presented at HIV Glasgow from the DOLCE ... DOLCE is a randomised, open-label, multicentre study assessing the efficacy and safety of DTG/3TC in 230 antiretroviral treatment (ART)-naïve ...